Xenon Pharmaceuticals Inc XENE
$62.35
-2.93%
at last close
Analyst Consensus
- Consensus Rating
- Buy (10 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $74.80
- Implied Upside
- +20.0%
- Price Target Range
- $55.00 – $97.00
- Analysts (12 mo)
- 10
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-07 | RBC CapitalBrian Abrahams |
Maintains | Outperform | $82 → $81 |
| 2026-05-27 | JP MorganTessa Romero |
Maintains | Overweight | $80 → $82 |
| 2026-05-12 | JP MorganTessa Romero |
Maintains | Overweight | $77 → $80 |
| 2026-05-08 | RBC CapitalBrian Abrahams |
Maintains | Outperform | $80 → $82 |
| 2026-05-08 | NeedhamSerge Belanger |
Maintains | Buy | $80 → $78 |
| 2026-03-16 | WedbushLaura Chico |
Maintains | Outperform | $64 → $63 |
| 2026-03-10 | Wells FargoBenjamin Burnett |
Maintains | Overweight | $49 → $68 |
| 2026-03-10 | WedbushLaura Chico |
Maintains | Outperform | $47 → $64 |
| 2026-03-10 | Deutsche BankDavid Hoang |
Maintains | Buy | $56 → $90 |
| 2026-03-10 | HC Wainwright & Co.Douglas Tsao |
Maintains | Buy | $53 → $74 |
| 2026-03-09 | NeedhamSerge Belanger |
Maintains | Buy | $58 → $80 |
| 2026-03-09 | BairdBrian Skorney |
Maintains | Outperform | $63 → $97 |
| 2026-02-27 | NeedhamSerge Belanger |
Maintains | Buy | $55 → $58 |
| 2026-02-27 | Wells FargoBenjamin Burnett |
Maintains | Overweight | $48 → $49 |
| 2026-02-24 | Wolfe ResearchRudy Li |
Initiates coverage on | Outperform | $60 |
| 2026-01-09 | JP MorganTessa Romero |
Maintains | Overweight | $60 → $62 |
| 2025-12-11 | Wells FargoBenjamin Burnett |
Maintains | Overweight | $44 → $48 |
| 2025-11-18 | JP MorganTessa Romero |
Maintains | Overweight | $57 → $60 |
| 2025-11-04 | RBC CapitalBrian Abrahams |
Maintains | Outperform | $55 → $58 |
| 2025-11-04 | Wells FargoBenjamin Burnett |
Maintains | Overweight | $48 → $44 |
| 2025-11-04 | NeedhamSerge Belanger |
Reiterates | Buy | $55 |
| 2025-10-07 | Chardan CapitalRudy Li |
Maintains | Buy | $55 |
| 2025-09-03 | Wells FargoBenjamin Burnett |
Assumes | Overweight | $48 |
| 2025-09-02 | RBC CapitalBrian Abrahams |
Reiterates | Outperform | $55 |
| 2025-08-12 | Chardan CapitalRudy Li |
Maintains | Buy | $55 |
| 2025-08-12 | RBC CapitalBrian Abrahams |
Maintains | Outperform | $57 → $55 |
| 2025-08-12 | WedbushLaura Chico |
Maintains | Outperform | $42 → $43 |
| 2025-05-14 | Evercore ISI GroupCory Kasimov |
Initiates coverage on | Outperform | $55 |
| 2025-05-13 | Wells FargoMohit Bansal |
Maintains | Overweight | $50 → $47 |
| 2025-05-13 | RBC CapitalBrian Abrahams |
Maintains | Outperform | $58 → $55 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $62.35
- Market Cap
- $6.31 billion
- 52-Week Range
- $30.00 – $72.66
- Average Volume
- 1.02 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.